Prudential Financial’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Buy
95,115
+78,450
+471% +$1.39M ﹤0.01% 1431
2025
Q4
$312K Buy
+16,665
New +$276K ﹤0.01% 1969
2025
Q2
Sell
-10,140
Closed -$90.5K 2511
2025
Q1
$90.5K Buy
+10,140
New +$94.4K ﹤0.01% 2138
2024
Q4
Sell
-57,240
Closed -$461K 2684
2024
Q3
$461K Buy
+57,240
New +$496K ﹤0.01% 2250
2023
Q4
Sell
-16,505
Closed -$142K 2715
2023
Q3
$142K Sell
16,505
-4,680
-22% -$45.2K ﹤0.01% 2424
2023
Q2
$219K Buy
21,185
+5,400
+34% +$59.6K ﹤0.01% 2412
2023
Q1
$171K Buy
+15,785
New +$167K ﹤0.01% 2419
2019
Q1
Sell
-9,270
Closed -$237K 2467
2018
Q4
$237K Sell
9,270
-40
-0.4% -$1.08K ﹤0.01% 2196
2018
Q3
$304K Sell
9,310
-140
-1% -$3.82K ﹤0.01% 2195
2018
Q2
$214K Buy
+9,450
New +$224K ﹤0.01% 2328

Other funds holding TBPH